Doctor Sandra J. Sha grew up in Los Angeles, California. She attended the University of California at Berkeley. Dr. Sha graduated in the top 10% of her class earning a BA in Biology with Distinction in General Scholarship and made the Dean's Honor Roll every semester. She was elected to the prestigious Phi Beta Kappa, the nation's largest and oldest academic honor society, as well as the Golden Key International Honor Society .
She attended Tufts University School of Medicine in Boston, Massachusetts, earning her Medical Degree. In medical school, Dr. Sha was a member of American Medical Women's Association, a national organization committed to advancing women's health. She was involved in community service by volunteering on a monthly basis in a women's shelter in Boston. She also participated in a handful of outreach programs designed to help underserved women register to vote.
During medical school, her research in women's health led to an article publication in the ''American Journal of Perinatology.'' During her residency, she took part in research pointed at further enhancing the refinement of radiation planning and was published in ''Artificial Intelligence in Medicine.''
Dr. Sha participates actively in the American Cancer Society and is attainable for speaking engagements. She specializes in all radiation oncology areas, but has a distinct interest in Women's Health for breast cancer treatment and research.
In January 2004, she proudly joined the Central Florida Cancer Institute. Dr. Sandra Sha has offices in Lakeland, Lake Wales and Davenport.
Learn more about this radiation alternative treatment for breast cancer. The Contura device is part of a new class of treatment options designed to reduce the total amount of time spent undergoing radiation therapy, offering a five-day care plan as opposed to the traditional six weeks, returning patients to everyday living as soon as possible.
The Coherex FlatStent PFO Closure System was first used on a human patient in October of 2007 in Frankfurt, Germany. The procedure was done under the direction of Interventional Cardiologist Professor Horst Sievert, M.D. The Ceherex FlatStent was used to close a heart defect commonly referred to as PFO.
The world of medicine is constantly bringing us new, exciting discoveries; and the 2008 FDA approval of the Endeavor Drug-Eluting Stent is yet another amazing advancement. The device has so far proven to be quite effective in helping heart patients with narrowed coronary arteries.
In order to treat spine disorders in the least invasive way possible, TranS1 creates a different approach. With 15-30% of the U.S. population experiencing lower back disorders, there is a need to treat the underlying conditions in the most effective way possible. Disc degeneration is most often the cause of this discomfort, and current treatment usually calls for the complete removal of the disc and the fusion of the vertebrae.